R-56865

CN(C1CCN(CCCCOC2=CC=C(F)C=C2)CC1)C3=NC4=C(S3)C=CC=C4

InChIKey=PZPXREFPAFDHNG-UHFFFAOYSA-N

InChI=1S/C23H28FN3OS/c1-26(23-25-21-6-2-3-7-22(21)29-23)19-12-15-27(16-13-19)14-4-5-17-28-20-10-8-18(24)9-11-20/h2-3,6-11,19H,4-5,12-17H2,1H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Pharmacological characterisation of sodium channels in sinoatrial node pacemaking in the rat heart.	2006-01-20	16368090
R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent manner.	1993-08	8221803

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:06:38 GMT 2025` Edited by `admin` on `Mon Mar 31 19:06:38 GMT 2025`
Record UNII	8MUQ2U7UV6
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

2-BENZOTHIAZOLAMINE, N-(1-(4-(4-FLUOROPHENOXY)BUTYL)-4-PIPERIDINYL)-N-METHYL-

Preferred Name

English

R-56865

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID40146613

Created by admin on Mon Mar 31 19:06:38 GMT 2025 , Edited by admin on Mon Mar 31 19:06:38 GMT 2025

PRIMARY

PUBCHEM

108043

Created by admin on Mon Mar 31 19:06:38 GMT 2025 , Edited by admin on Mon Mar 31 19:06:38 GMT 2025

PRIMARY

FDA UNII

8MUQ2U7UV6

Created by admin on Mon Mar 31 19:06:38 GMT 2025 , Edited by admin on Mon Mar 31 19:06:38 GMT 2025

PRIMARY

CAS

104606-13-5

Created by admin on Mon Mar 31 19:06:38 GMT 2025 , Edited by admin on Mon Mar 31 19:06:38 GMT 2025

PRIMARY

Related Record Type Details


					8MUQ2U7UV6

R-56865

ACTIVE MOIETY